May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Assessment of Meibomian Lipids in Postmenopausal Women Using Electrospray Ionization Mass Spectrometry
Author Affiliations & Notes
  • K.K. Nichols
    Optometry,
    Ohio State University, Columbus, OH
  • L. Young
    Optometry,
    Ohio State University, Columbus, OH
  • K. Green–Church
    Mass Spectrometry and Proteomics Facility,
    Ohio State University, Columbus, OH
  • C. Ziegler
    Optometry,
    Ohio State University, Columbus, OH
  • J.J. Nichols
    Optometry,
    Ohio State University, Columbus, OH
  • Footnotes
    Commercial Relationships  K.K. Nichols, None; L. Young, None; K. Green–Church, None; C. Ziegler, None; J.J. Nichols, None.
  • Footnotes
    Support  Ohio Lions Eye Research Foundation
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4446. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K.K. Nichols, L. Young, K. Green–Church, C. Ziegler, J.J. Nichols; Assessment of Meibomian Lipids in Postmenopausal Women Using Electrospray Ionization Mass Spectrometry . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4446.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:Electrospray ionization time–of–flight mass spectrometry (ESI–TOF) was used to characterize meibomian gland lipid from postmenopausal women with and without dry eye. Methods:Meibomian gland secretions were collected from 15 postmenopausal women using a sterile 1.5mm curette probe. The secretions were stored in a 2:1 chloroform/ methanol solution and frozen at –70° C until analysis. Meibomian gland secretions were directly infused at 20 µL/min to a Micromass LCT equipped with an orthogonal electrospray source (Z–spray) which was operated in positive ion mode. Clinical tests performed (right eye) included: symptom and history surveys, osmolarity, non–invasive and fluorescein tear break–up, meibomian gland evaluation, infrared meibography, fluorescein corneal staining, lissamine green conjunctival staining, and the phenol red thread test. Results:Of the sample, 26.7% (4/15) reported a previous dry eye diagnosis, although 46.7% (7/15) use artificial tears on a routine basis. Average osmolarity was 312.4 ± 28.9 mOsm, average fluorescein tear break–up time was 7.3 ± 2.4 sec., average thread wetting was 24.5 ± 5.9 mm/15 seconds, 40.0% demonstrated any corneal staining, and 73.3% showed mild (1–25%) meibomian gland drop–out on meibography. No statistically significant differences were found in mentioned clinical test results between patients reporting/not reporting a previous dry eye diagnosis. The most prominent peaks observed in the lipid profiles are as follows: 304.2, 489.2, 585.5, 770.5, and 955.6. A peak at 727.5 (thought to be sphingomyelin) was absent in the majority of profiles. The peak at 304.2 has been identified as oleamide + sodium. Conclusions: It remains a challenge to classify patients as "dry eye" on the basis of symptoms and clinical test results or even a previous "dry eye diagnosis." Comparison of lipid profiles and assessment of peak strength (quantification) may yield further information particularly with the presence or absence of specific molecular weight peaks.

Keywords: cornea: tears/tear film/dry eye • lipids 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×